Abstract. Peritonitis is an inflammatory process characterized by massive monocytes-macrophages infiltration. Since early diagnosis is important for a successful therapeutic outcome, the feasibility for a selective labeling and imaging of macrophages for highly sensitive optical imaging was assessed. After in vitro incubation of mouse macrophages J774A.1 with the far-red/near-infrared fluorochrome DY-676, distinct fluorescence intensities ͑1026± 142 a.u.͒ were detected as compared to controls ͑552± 54 a.u.͒ using a whole-body small animal near-infrared fluorescence ͑NIRF͒ imaging system. Macrophage labeling was confirmed by confocal laser scanning microscopy ͑CLSM͒ and fluorescence-activated cell sorting, ͑FACS͒. The fluorochrome was also found to be predominantly distributed within compartments in the cytoplasm. Additionally, peritonitis was induced in mice by intraperitoneal injection of zymosanA. After intravenous injection of fluorochrome ͑55 nmol/ kg͒ and using whole-body fluorescence imaging, higher fluorescence intensities ͑869± 151 a.u.͒ were detected in the peritoneal area of diseased mice as compared to controls ͑188± 41 a.u.͒. Furthermore, cells isolated from peritoneal lavage revealed the presence of labeled monocytes-macrophages. The results indicate that in vivo diagnosis of peritonitis by near-infrared optical imaging of labeled monocytes-macrophages is feasible. Possibly, early stages of other inflammatory diseases could also be detected by the proposed diagnostic method in the long term.
Introduction
Peritonitis is an inflammatory process that can arise from various causes, including infectious, chemical, iatrogenic, and other etiologies. Patients with peritonitis have fever and suffer from abdominal pain and emesis. Various reasons are often described to be responsible for the disease, for instance, the infection of abdominal organs ͑e.g., the pancreas͒ or injuries during surgical interventions. 1, 2 Even starch or talc from surgical gloves may provoke an abdominal inflammation. 3 In women, peritonitis often occurs after bacterial infection of the uterus. 4 Moreover, patients with kidney failures treated by peritoneal dialysis commonly suffer from this disease. 5 If untreated, there are many complications resulting from peritonitis that may emerge quite rapidly, such as kidney, lung, and liver failures. 6 Nevertheless, the current diagnostic methods are based on the symptoms and are limited to the application of invasive procedures such as abdominal paracentesis for the assessment of the abdominal fluid in relation to the presence of germs. 7, 8 Using radiologic methods, x-ray detections can suggest the presence of the condition, but the diagnostic potential is limited to anatomical information. 9 Occasionally, magnetic resonance tomography ͑MRT͒ is used for abdominal imaging and can provide information about inflammatory processes in this cavity. Nevertheless, early detection is not possible by using MRT, particularly because it lacks sensitivity in comparison to other progressive techniques, like positron emission tomography ͑PET͒ in nuclear medicine, which is based on radioactive probes as cellular or molecular markers.
At the cellular level, peritonitis, like other inflammatory processes, is characterized by a massive leukocyte infiltration, 10 such as activated monocytes-macrophages into the target tissue 6 to 24 h after onset of inflammation. 11, 12 Activation of the monocytes-macrophages population takes place at the highly vascularized internal mucosa layers, 13 where those cells could theoretically be effectively labeled with the aforementioned probes for imaging purposes. The use of farred and near-infrared fluorescence imaging for the highly sensitive detection of changes on the molecular and cellular level is very attractive. Benefited by the increased capacity of light at wavelengths between 600 and 950 nm to penetrate tissues up to a few centimeters, 14, 15 fluorochromes, such as indodicarbocyanine ͑IDCC; exc. : 650 nm; em : 670 nm͒, Cy5.5 ͑ exc : 675 nm, em : 694 nm͒ or indocyanine green ͑ICG, exc : 780 nm, em : 830 nm͒ have been used to image specific molecular markers of different diseases. [16] [17] [18] [19] In contrast to this, since one of the typical features of macrophages is their phagocytotic activity, it should be possible to simply accumulate fluorochrome in macrophages recruited within inflammatory areas, as this is likely to occur in peritonitis without the need of highly sophisticated contrast agents. Whereas most investigations deal with ex vivo labeling using magnetic nanoparticles 20, 21 or fluorochromes, 22 in vivo fluorochrome tagging of cells has been only poorly considered for imaging until now. [23] [24] [25] With the far-red and near-infrared optical methods, a new noninvasive technique has entered the diagnostic field in recent years. [26] [27] [28] One particular advantage of this technique is that it can be operated with low costs, easy handling, and without radioactivity.
Therefore, using a novel hemicyanine dye DY-676 ͑ exc : 676 nm; em : 701 nm͒ with far-red/near-infrared fluorooptical properties, we addressed the following issues:
• Whether it is possible to label macrophages and to detect them with a whole-body small animal near-infrared imaging system in vitro by verifying macroscopic in vitro data using flow cytometry and laser scanning microscopy • Whether it is possible to label monocytes-macrophages in vivo in a peritonitis animal model for diagnostic imaging with the whole-body small animal near-infrared fluorescence ͑NIRF͒ imaging system.
Material and Methods

Cell Culture
Cells from mouse macrophage cell line J774A.1 ͑Cell Lines Service, Heidelberg, Germany͒ were cultured in DMEM ͑Dul-becco Modified Eagle medium; GIBCO BRL, Paisley, Scotland͒ with 10% ͑v/v͒ FCS ͑fetal calf serum; GIBCO BRL, Paisley, Scotland͒ at 37°C in a 5% CO 2 atmosphere and 95% humidity. To label 1.5ϫ 10 6 macrophages, cells were incubated for 3 h with the DY-676 ͑7.7 nmol/ ml͒ or with culture medium only as control for autofluorescence. After washing 10 times with PBS ͑phosphate buffered saline, 100 mM, pH 7.4͒ to remove noninternalized dye molecules, cells were scraped from the bottom of the culture dishes and resuspended in PBS for further analysis.
In Vitro Far-Red/Near-Infrared Fluorescence Imaging
Before harvesting, fluorochrome labeled cells were imaged with a planar fluorescence reflectance system, the whole-body small animal near-infrared fluorescence imager ͑bonSAI, Siemens, Erlangen, Germany͒, using the 660/ 735-nm filters for excitation and emission at an acquisition time of 2.0 s with binning factor 2 ͑512ϫ 696 pixels matrix size͒. Fluorescence signals were detected with a charge-coupled device camera ͑pixel size 4.6ϫ 4.6 m͒ and images ͑regions of interest, ROI͒ were semiquantitatively analyzed with the SYNGO software ͑Siemens, Erlangen, Germany͒. Fluorescence intensities ͑signal intensities in arbitrary units͒ were presented as means± standard deviations. Comparisons of mean fluorescence intensities between labeled and nonlabeled macrophages were performed by means of Students t-test for independent samples.
Flow Cytometry Analysis
In vitro NIRF imaging of macrophages labeled for 24 h with DY-676 was further characterized with a FACSCalibur analytical instrument using the fluorescence channel 3 ͓FL3, 670-nm long pass ͑lp͔͒ and the CellQuest software ͑Becton Dickinson, Heidelberg, Germany͒. For cell viability testing, cell samples were incubated with 2 g/ml propidium iodide ͑Sigma-Aldrich, Steinheim, Germany͒ for 10 min and fluorescence emission was detected with the fluorescence channel 2 ͓FL2, 585/ 42-nm bandpass ͑bp͔͒.
Laser-Scanning Microscopy
In order to further verify macrophage cell labeling, 10 5 cells incubated with DY-676 ͑3 h, 7.7 M͒ or with culture medium only were additionally sedimented and air-dried on Histobond object slides ͑Marienfeld, Bad Mergentheim, Germany͒, stained with 10 g/ml 4Ј-6-diamidino-2-phenylindole ͑DAPI, Sigma-Aldrich, Steinheim, Germany͒, and embedded with Permafluor ͑Immunotech, Marseille, France͒. Confocal laser scanning microscopy was performed using a LSM510 system with the LSM510 image examiner software ͑Zeiss, Jena, Germany͒.
In Vivo NIRF Imaging of Peritonitis in a Mouse Model
Nine 8-week-old male NMRI mice weighting approximately 23 g were housed under standard conditions with food and water ad libitum. Seven days prior to the start of experiments, all mice received a low pheophorbide diet ͑Altromin, Lage, Germany͒ in order to reduce autofluorescence of abdominal organs. At the beginning of the experiments, all animals were shaved on the ventral area. Animals were split into three groups ͑i͒, ͑ii͒, and ͑iii͒, with three animals per group. Peritonitis was induced in mice of groups ͑i͒ and ͑ii͒ by intraperitoneal injection of 3 mg of zymosanA ͑Sigma-Aldrich, Steinheim, Germany͒ dissolved in 400 l of PBS according to Parente et al. 29 Immediately after induction of peritonitis, mice from group ͑i͒ received DY-676 at a dose of 55 nmol of fluorochrome per kg body weight into the tail vein. Group ͑ii͒ was not injected with fluorochrome as a control for autofluorescence of macrophages within the target region of diseased mice. Mice from group ͑iii͒ got an intraperitoneal injection of 400 l of PBS ͑no peritonitis induction͒ followed by i.v. application of DY-676 as a control for unspecific accumulation of dye in the target region of nondiseased mice. All mice were imaged directly before and at 6 h after ͑when monocytemacrophage recruitment starts to increase, as reported by Ajuebor et al. 13 ͒ induction of peritonitis using the whole-body small animal near-infrared fluorescence imaging system, as described earlier. The acquisition time was 0.5 s with binning factor 1 ͑1024ϫ 1392 pixels matrix size͒. Statistical analysis was performed as described earlier. All procedures were approved by the regional animal committee and were in accordance with international guidelines on the ethical use of animals.
Ex Vivo NIRF Imaging of Peritonitis
6 h after peritonitis induction, the mice were sacrificed and ex vivo whole-body NIRF imaging of the opened mice was performed. Afterward, the liver, spleen, and kidneys were withdrawn and imaged as well for assessment of whole-organ fluorescence. The acquisition time was 0.5 s together with a binning factor of 1. Statistical analysis was performed as described earlier. Pieces of the small intestine were snap-frozen, and 6-m thin sections were immunostained with DAPI and rat anti-mouse CD68 fluoresceinisothiocyanate ͑FITC͒-conjugate ͑Biozol, Eching, Germany͒ or rat IgG2a FITC ͑Serotec, Oxford, UK͒ as isotype control, respectively, for confocal laser scanning microscopy with the Zeiss LSM510 system.
Isolation and NIRF Imaging of Peritoneal Lavage
In order to verify that in vivo NIRF imaging was based on the presence of fluorochrome labeled monocytes-macrophages at the inflamed peritoneal region, all mice received a peritoneal lavage immediately after sacrifice. Hereby, peritoneal cavities were washed with 5 ml of PBS containing 2 mM of ethylenediaminetetraacetic acid ͑EDTA͒. The cellular fraction was isolated by centrifugation. In order to assess the presence of fluorochrome labeled cells, pellets containing 5 ϫ 10 6 cells were imaged with the whole-body small animal near-infrared imaging system as described earlier ͑acquisition time of 2.0 s and a binning factor of 2͒. Afterward, cells from peritoneal lavages were then fixated with 3% paraformaldehyde for 15 min followed by careful washing and staining on ice with rat anti-mouse F4/80 FITC conjugate ͑Dianova, Hamburg, Germany͒ for 30 min. After extensive washing, cells were analyzed by flow cytometry using the FACSCalibur analytical instrument.
Results
In Vitro NIRF Imaging of Labeled Macrophages
Analyses with the whole-body small animal near-infrared fluorescence imaging system showed that fluorochrome labeled macrophages grown on Petri dishes could be clearly identified. After incubation of cells for 3 h with DY-676 ͑7.7 M͒, distinct fluorescence intensities were detected ͓Fig.
1͑a͒ and 1͑c͔͒ as compared to macrophages incubated with medium only ͓Fig. 1͑b͒ and 1͑d͔͒. Semiquantitative analysis showed significantly increased ͑P ഛ 0.001͒ fluorescence intensities of labeled macrophages ͑1026± 142 a.u.͒ as compared to controls ͓552± 54 a.u., Fig. 1͑e͔͒ .
The fact that macrophages were, indeed, labeled with the fluorochrome DY-676 was further verified by laser scanning microscopy. It was shown that DY-676 was stored inside the cells. Moreover, no homogeneous distribution inside the cells was observed, but predominantly in compartments with high fluorescence intensity indicating an localized accumulation of fluorochrome ͑Fig. 2͒. Flow cytometry analysis revealed that macrophages treated with DY-676 could be clearly distinguished from macrophages that have been incubated with medium only ͓Fig. 3͑a͒ and 3͑c͔͒. As observed by fluorescenceactivated cell sorting ͑FACS͒ analysis, more than 99% of all cells in the sample were labeled with the fluorochrome. FACS analysis of propidium-iodide-stained cells revealed that both samples ͑with and without fluorochrome incubation͒ contained 85% viable ͑propidium iodide negative͒ and 15% nonviable cells ͑propidium iodide positive͒ after harvesting ͓Fig. 3͑b͒ and 3͑d͔͒.
In Vivo NIRF Imaging of Peritonitis
Whole-body small animal near-infrared fluorescence imaging showed that 6 h after induction of peritonitis in mice that received the fluorochrome DY-676 ͓55 nmol/ kg, Fig. 4͑a͒ and 4͑b͔͒, a distinct fluorescence area was depictable at the left abdominal side, where zymosanA was previously injected. In comparison, control mice without peritonitis ͑injec-tion of PBS instead of zymosanA͒ that did receive DY-676 i.v. ͓Fig. 4͑e͒ and 4͑f͔͒ showed a spot at the abdominal area with a comparatively much lower fluorescence intensity. Nevertheless, mice having peritonitis that did not receive the contrast medium DY-676 ͓control for autofluorescence of monocytesmacrophages within the target region of diseased mice, Fig.  4͑c͒ and 4͑d͔͒ revealed no fluorescence at all. Semiquantita- tive analysis of mice abdominal areas showed that 6 h after induction of peritonitis, fluorescence intensities of the ventral areas with peritonitis ͓group ͑i͒, 869± 87 a.u.͔ were increased by a factor of 4 or higher compared to the data of both control groups ͑ii͒ ͑142± 35 a.u.͒ and ͑iii͒ ͓188± 24 a.u., Fig. 4͑g͔͒ . 7 Immunofluorescence staining of the small intestine of diseased mice. ͑a͒ NIRF ͑red, Ͼ650-nm lp͒, ͑b͒ CD68FITC, ͑c͒ merged with DAPI for DNA staining ͑blue͒, and ͑d͒ rat IgG2a FITC isotype control ͑green͒ images derived from a mouse 6 h after injection of DY-676. Arrows show CD68 + monocytes-macrophages located in the lamina propria of villi within the mucosa containing DY-676. Images ͑e͒ NIRF ͑red, Ͼ650-nm lp͒, ͑f͒ CD68FITC ͑green͒, ͑g͒ merged with DAPI for DNA staining ͑blue͒, and ͑h͒ rat IgG2a FITC isotype control ͑green͒ images derived from a diseased mouse without injection of DY-676 ͑scale bars= 50 m͒.
Ex Vivo NIRF Imaging of Peritoneal Lavage from Mice with and without Peritonitis
Analysis of cells isolated from peritoneal lavage using the whole-body small animal near-infrared imaging system ͓Fig. 
Ex Vivo NIRF Imaging of Mice with and without Peritonitis
The whole-body NIRF images of opened mice with peritonitis having received an i.v. injection of DY-676 showed areas of distinctly higher fluorescence intensities on the surface of the intestinal tract ͓Fig. 6͑a͒ and 6͑b͔͒ as compared to mice without peritonitis but with i.v. injection of DY-676 ͓Fig. 6͑c͒ and 6͑d͔͒.
Immunostaining of the small intestine from diseased mice that were injected with DY-676 clearly showed that CD68-positive monocytes-macrophages located in the lamina propria of villi within the mucosa revealed high fluorescence intensities in the far-red/near-infrared range ͓Fig. 7͑a͒-7͑c͔͒. Moreover, CD68-positive monocytes-macrophages between the crypts were found to be intracellularly loaded with DY-676 ͑data not shown͒. Whereas no fluorescence was observed using the FITC-labeled isotype control, far-red/near-infrared fluorescent spots were still detected within the centers of the lamina propria ͓Fig. 7͑d͔͒. Immunostaining of the small intestine from diseased mice without injection of DY-676 showed no fluorescence intensities in the far-red/near-infrared range ͓Fig. 7͑e͒-7͑h͔͒.
Whole-organ fluorescence analysis ͓Fig. 8͑a͒-8͑f͔͒ showed that some signal was detectable in the kidneys from mice both with and without peritonitis after application of the contrast medium DY-676 ͓Fig. 8͑d͒ and 8͑f͔͒. In comparison no fluorescence was observed in mice having received no DY-676 ͓Fig. 8͑d͔͒. Semiquantitative analysis supported the aforementioned findings ͓Fig. 8͑g͔͒. Particularly, low mean fluorescence intensities of 210 to 270 a.u. were detected in the kidneys of mice intravenously injected with DY-676, whereas the mean fluorescence intensities of all other organs were even lower than 100 a.u.
Discussion
Our results revealed that monocytes-macrophages could be efficiently labeled with DY-676 and imaged in vitro and in vivo using a whole-body near-infrared fluorescence imaging system.
The in vitro experiments with mouse macrophage cell line J774A.1 showed that cells could be selectively imaged with a whole-body small animal imaging system after labeling with DY-676. Macrophage labeling with DY-676 was clearly verified by FACS analysis; however, as compared to the aforementioned results, semiquantitative analysis of the images obtained from the whole-body small animal imaging system showed relatively higher fluorescence intensities of nonlabeled cells in relation to the labeled ones. These findings can be attributed to the reflective effects of the culture dishes' smooth surface. Further on, FACS analysis using propidium Lisy et al.: Diagnosis of peritonitis using near-infrared optical imaging… iodide revealed that incubation with fluorochrome for 24 h does not affect cell viability. The histogram blots showed that there were only 15% of death cells both in DY-676 labeled and in nonlabeled samples. The presence of dead cells was probably caused by scraping off from the plastic matrix. With respect to the in vivo situation, this observation basically indicates that labeling of macrophages with fluorochromes should not have an impact on cell viability. Moreover, DY-676 was predominantly stored within defined structures of the cytoplasm, which is presumably caused by the active uptake into organelles like endosomes during phagocytosis. The exact mechanisms for uptake of fluorochromes in macrophages are not clear yet. Nevertheless, active phagocytosis of dyes after binding to serum albumin has been already discussed 24 in relation to the application of Cy5.5. Since the chemical structure of DY-676 is similar to that of Cy 5.5, it is conceivable that some unspecific binding of the dye to serum proteins takes place. In this case, dye uptake by macrophages occurs via phagocytosis.
In vivo whole-body fluorescence imaging of mice at 6 h after zymosanA-induced peritonitis showed that mice suffering from this disease could be clearly distinguished from controls, indicating that, basically, an early specific identification of the disease is possible using optical methods. Due to the fact that clearance of the fluorochrome in healthy mice takes between 4 and 6 h and as we intended to demonstrate feasibility to image early stages of inflammation, when monocytes-macrophages start to migrate to the target area, it was necessary to inject the contrast agent immediately after induction of peritonitis. Other studies reported that monocytemacrophage infiltration takes place for more than 24 h. 11, 13 Therefore, peritonitis could also be detected at later points in time, which has to be proven in further studies. Considering the clinical situation, a very effective monitoring of patients, e.g., during surgery, could be performed when monocytesmacrophages start to migrate to the target area, but further studies are necessary to elucidate to what extent the characteristics of the peritonitis model used in the present study are transferable to human beings.
All fluorescence data shown in the present study are based on semiquantitative analysis of intrinsic values of the CCD camera calculated by the SYNGO software. The influence of inhomogeneous absorptive behaviour, reflection, or scattering properties 30 of the samples or tissues investigated in this study could not be considered. Nevertheless, as equivalent experimental conditions were used, the interpretation of semiquantitative data is legitimate to show tendencies. The observed differences between the contrast in in vitro and in vivo experiments are not clear, but it is conceivable that the unspecific reflections in relation to the Petri dishes used in the present study in the in vitro situation may have influenced the results.
The aforementioned in vivo observations are in agreement with the results from ex vivo examinations showing that the application of the contrast medium led to a selective labeling of macrophages recruited at the target site. These results are reinforced, in principle, by the fact that the animal model used is known to be characterized by a massive recruitment of activated monocytes-macrophages into the peritoneum at the area of zymosanA injection, which increases between 6 h and 24 h after induction of peritonitis. 13 Presumably, in vivo uptake of DY-676 by monocytes-macrophages occurs in well vascularized mucosa layers before immigration into the inflamed region takes place. This assumption is reinforced by the observations of Ajuebor et al., 13 who reported a pronounced migration of monocytes-macrophages from the peritoneum to the internal mucosa layers followed by a reappearence at the area of zymosanA injection. Further studies should consider and verify these relationships in more detail as well as identify to what extent they apply in connection with the situation in humans.
The presence of fluorochrome labeled cells in peritoneal lavages extracted from the inflamed region could be confirmed by analysis of NIRF images of cell sediments. In particular, the strong fluorescence of the cell sediments derived from the diseased mice after i.v. DY-676 application corresponds well to the in vivo results. The weak signal of the isolated cells from the mice without peritonitis that received only contrast agent might be caused by the presence of labeled monocytes-macrophages in consequence of the intervention itself, as demonstrated by the injection of harmless PBS instead of zymosanA. As expected from the in vivo results, no fluorescent cells could be found in cells from diseased mice that were not injected with the DY-676, indicating that autofluorescence emerging from monocytes-macrophages per se or zymosanA itself had no effects on the observed fluorescence signals.
The fact that in vivo the fluorochrome DY-676 was mainly taken up by monocytes-macrophages was demonstrated by FACS analysis. Hereby, cells expressing intermediate and high levels of F4/80 antigen were found to show fluorescence intensities in the far-red/near-infrared range. Moreover, these results are consistent with previous reports 13, 31 showing that the F4/80 antigen is expressed on monocytes-macrophages reappearing very early at the area of zymosanA injection up to 24 h after onset of peritonitis. Further on, it was reported that after immunostaining of cells from peritoneal lavages against the F4/80 antigen, three subpopulations ͑lymphocytes-nonexpressing; monocytes-intermediate levels; and macrophages-high levels͒ were identified. 13 In accordance with that study, we state that monocytes-macrophages could be identified as the fraction of cells in the peritoneal lavage collected containing the contrast agent DY-676. Moreover, the fact that in vivo whole-body fluorescence signals are based on fluorochrome labeled monocyte-macrophages is further reinforced by immunofluorescence analysis of the small intestine from the area of zymosanA injection.
Whereas the results indicate that the detected fluorescence signals are mainly associated with labeled cells, a nonspecific accumulation of fluorochrome at the target region seems to be unlikely because controls injected with PBS only instead of the zymosanA suspension showed only very weak fluorescence in vivo at the target site. This is supported by the ex vivo images of opened control mice, where only very low fluorescence intensities could be detected on the surface of the intestinal tract, due to the lack of an increased monocytemacrophage population.
Compared to the fluorescence signals observed in the peritoneal area of zymosanA injection, only very low signals were detectable in the withdrawn highly vascularized organs, like the kidneys, liver, and spleen. Particularly for the kidneys, the determined "out of body" fluorescence values are lower by a factor of 3 in comparison to the results from the in vivo images. Moreover, in vivo whole-body imaging of mice without peritonitis injected with DY-676 revealed no detectable fluorescence in the liver and kidneys. Therefore, the low signal intensities in these vascularized organs should not have contributed to the observed fluorescence intensity at the inflamed abdominal region.
The very low signals emitted from the kidneys suggest a fast renal clearance mechanism of the fluorochrome that would be an advantage in relation to those macromolecular contrast agents with a predominant hepatic deposition and metabolism, like the clinically used indocyanine green 32 or the previously reported high-affinity contrast agents, where fluorochrome molecules ͑e.g., Cy5.5͒ were coupled to macromolecular antibodies ͑e.g., Herceptin͒ for tumor imaging. 23, 33 This is, to the best of our knowledge, the first time that peritoneal macrophages have been efficiently labeled and imaged using fluorochrome dyes.
Whereas the results of the present study indicate that peritonitis could be selectively detected by optical methods, one of the possible limitations of this method consists of the lack of an adequate anatomical resolution that is associated with the optical systems available up to now. The in vivo findings presented here are based on planar fluorescence reflectance imaging. No real tomographic information for exactly threedimensional resolution of the inflammatory areas was available. Nevertheless, different techniques like the very interesting approaches 34 related to fluorescence mediated tomography ͑FMT͒ or the combination of NIRF imaging with other tomographic devices should be valuable tools for providing further detailed information about the respective inflammatory region.
The present study shows that monocyte-macrophage cultures can be successfully labeled and imaged in their original size using a fluoro-optical contrast medium and that, accordingly, selective macrophage labeling and whole-body imaging could also be performed in the in vivo situation, particularly in relation to the detection of peritonitis as demonstrated in an animal model. Furthermore, labeling of monocytesmacrophages with DY-676, as shown in the present study, as well as using other potentially nontoxic NIRF fluorochromes, can be suitable for clinical diagnostics of other inflammatory diseases. In that case, this technology would be limited to diseases that are located only a few centimeters below the skin, due to the limited penetration depth of far-red/nearinfrared light. In our study, we intended to show the basic feasibility using planar optical imaging whereby light penetration into tissue is limited. However, based on the fact that peritonitis is localized only a few cm under the skin surface, it is conceivable that peritonitis in humans could be detected with fluorescence-mediated tomography ͑penetration depth Ͼ10 cm; Ref. 34͒. For more detailed in vivo imaging of developing inflammatory processes, additional studies should focus on specific target molecules such as cytokines and their receptors.
